Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: history of present illness: is the former 820 gram product of a 27-5/7 week gestation pregnancy born to a 26 year-old gravida ii, para 0 woman. prenatal screens: blood type o positive, antibody negative, rubella nonimmune, hepatitis b surface antigen, rpr nonreactive, group beta strep status unknown. the mother's medical history is significant for a liver transplant performed in due to chronic hepatitis b infection. during the pregnancy the mother was treated epivir and cyclosporins. she developed preeclampsia and transferred from hospital to for observation. she was treated with labetalol and magnesium sulfate with some improvement but due to persistent hypertension the infant was delivered after the mother became beta complete on . there were normal fetal surveys and 1 elevated alpha fetoprotein but other levels were normal. the infant was delivered by cesarean section due to breech presentation. apgars were 7 at one minute and 8 at five minutes. she emerged with fair respiratory effort but had developed significant respiratory distress and was intubated in the delivery room and admitted to the neonatal intensive care unit for further treatment. there was no maternal fever or intrapartum antibiotic treatment prior to delivery. physical examination: upon admission to the neonatal intensive care unit: weight 820 grams, length 33.5 cm. head circumference 24.5 cm, all parameters 10th to the 25th percentile. general: nondysmorphic preterm infant, 1 eyelid fused. head, eyes, ears, nose and throat: anterior fontanelle open and level. sutures apposed. orally intubated. palate intact. chest: breath sounds decreased bilaterally but equal. mild intercostal and subcostal retractions. cardiovascular: regular rate and rhythm. no murmur. normal s1 and s2. abdomen soft, nontender, nondistended. three vessel cord. gu: normal preterm female genitalia. anus patent. extremities: well perfused. tone appropriate for gestational age. neuro: reflexes consistent with gestational age. hospital course by systems including pertinent laboratory data: 1. respiratory: was placed on conventional ventilation and received 2 does of surfactant. by day of life #1 she had weaned to low ventilatory settings. she developed a metabolic acidosis secondary to a patent ductus arteriosus and received multiple doses of sodium bicarbonate. she was extubated to cpap on day of life #5 and continued on cpap through day of life #7 when she was changed to high flow nasal cannula o2 due to some necrosis of her nasal septum., a secondary complication of the cpap. she remained on high flow nasal cannula o2 to 1.5 liters per minute until day of life #25 when she was weaned to low flow cannula. at the time of discharge she is in 25 to 50 cc 100% nasal cannula. she has apnea of prematurity that is being treated with caffeine. at the time of discharge her baseline respiratory rate is 60 year-old 80 breaths per minute with mild intercostal retractions. she also received a course of vitamin a as prevention for possible chronic lung disease. 1. cardiovascular: received 1 course of indomethacin for a documented patent ductus arteriosus by cardiac echo. a repeat echo performed after the course of indomethacin on showed no pda with some left peripheral pulmonary artery stenosis noted. at the time of discharge she has no murmur and a baseline heart rate of 150 to 170 beats per minute. a recent blood pressure of 66/30 mmhg with a mean arterial pressure of 42. 1. fluids, electrolytes and nutrition: was initially npo and treated with intravenous fluids. enteral feeds were started on day of life #6 and gradually advanced to full volume. feedings have been well tolerated. at the time of discharge she is on 150 ml per kilo per day of similac special care 24 calorie fortified to 30 calories per ounce with 4 calories by medium chain triglyceride oil, 2 calories of polycose and additional propass protein supplement teaspoon per 100 ml of formula. weight on the date of discharge is 1.210 kilograms with a recent head circumference of 26 cm and a length of 37 cm. serum electrolytes were checked frequently in the first 2 weeks of life and were within normal limits. most recent nutrition laboratories were obtained on showing a calcium of 10 mg per dl, phosphorus of 8.3 and an alkaline phosphatase of 248. 1. infectious disease: due to the unknown etiology of the group beta strep status of the mother and the respiratory distress, was evaluated for sepsis upon admission to the neonatal intensive care unit. a blood culture was obtained prior to starting intravenous ampicillin and gentamicin. the blood culture was no growth at 48 hours and the antibiotics were discontinued. had some initial leukopenia which on repeat cbc had normalized. around the time of her nasal septal necrosis she was treated with topical bactroban ointment. there have been no other infectious disease issues during admission. of note, due to the mother's chronic hepatitis b status prior to her transplant was prophylactically treated with hepatitis b immune globulin and hepatitis b vaccine at the time of delivery. 1. hematological: is blood type a positive, direct antibody test negative. she received 1 transfusion of packed red cells on day of life #4. her most recent hematocrit is 29% with a reticulocyte count of 7.8% obtained on . she is being treated with supplemental iron. 1. gastrointestinal: required treatment of unconjugated hyperbilirubinemia with phototherapy. her most recent rebound bilirubin was on day of life #12 with a total of 1.7 mg per dl. 1. neurological: has maintained a normal neurological examination consistent with her gestational age. two head ultrasounds have been performed on and , , all showing totally normal results with no evidence of ivh or periventricular leukomalacia. 1. sensory: audiology: hearing screening is recommended prior to discharge. ophthalmology: will be due for her first eye examination the week of . 1. psychosocial: this is a very complex social situation. for details please contact the social worker, and she can be reached at or page operator beeper . condition on discharge: stable. discharge disposition: transfer to hospital for continuing level ii care. primary pediatrician has yet to be identified. care recommendations at the time of discharge: 1. feeding: 150 ml per kilo per day of similar special care premature formula 30 calories per ounce by gavage. 2. medications: caffeine citrate 7.3 mg pg once daily. vitamin e 5 units pg once daily. ferrous sulfate 0.2 ml of 25 mg per ml dilution pg daily. feeding additives: 4 calories as medium chain triglyceride oil, 2 calories of polycose and propass protein supplement teaspoon per 100 ml formula. 3. car seat position screening is recommended prior to discharge. 4. state newborn screens have been sent 3 times. the initial screen sent on was positive for 1 mutation of cystic fibrosis. this baby has been identified to be at least a carried and will need eventual flood testing. repeat screens on and have shown consistent similar results with other results within normal limits. initial hypothyroidism seen on first screen has resolved. 5. immunizations received: hepatitis b vaccine and hepatitis immune globulin were administered on . a second does of hepatitis b vaccine is recommended at 2 months as part of the 2 month immunizations. 6. immunizations recommended: synagis rsv prophylaxis should be considered from through who meet any of the following 3 criteria: 1) born at less than 32 weeks; 2) born between 32 and 35 weeks with 2 of the following: day care during the rsv season, a smoker in the household, neuromuscular disease, airway abnormalities, or school age siblings; or 3) with chronic lung disease. influenza immunization is recommended annually in the fall for all infants once they reach 6 months of age. before this age and for the first 24 months of the child's life, immunization against influenza is recommended for household contact and out of home care-givers. follow up appointments scheduled or recommended: 1. follow up sweat testing to determine cystic fibrosis status. 2. screening hip ultrasound for history of breech delivery. discharge diagnoses: 1. prematurity at 27-5/7 weeks gestation. 2. respiratory distress syndrome. 3. patent ductus arteriosus, status post treatment with indocin. 4. sepsis ruled out. 5. unconjugated hyperbilirubinemia. 6. apnea of prematurity. 7. anemia of prematurity. 8. status post nasal septal necrosis. 9. chronic lung disease. , procedure: venous catheterization, not elsewhere classified continuous invasive mechanical ventilation for 96 consecutive hours or more parenteral infusion of concentrated nutritional substances insertion of endotracheal tube enteral infusion of concentrated nutritional substances non-invasive mechanical ventilation arterial catheterization other phototherapy prophylactic administration of vaccine against other diseases transfusion of packed cells umbilical vein catheterization diagnoses: single liveborn, born in hospital, delivered by cesarean section need for prophylactic vaccination and inoculation against viral hepatitis observation for suspected infectious condition extreme immaturity, 750-999 grams respiratory distress syndrome in newborn neonatal jaundice associated with preterm delivery chronic respiratory disease arising in the perinatal period 27-28 completed weeks of gestation primary apnea of newborn patent ductus arteriosus anemia of prematurity other specified conditions originating in the perinatal period stenosis of pulmonary valve, congenital late metabolic acidosis of newborn 

Answer: The patient is high likely exposed to